Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 260


Diagnostic SOX10 gene signatures in salivary adenoid cystic and breast basal-like carcinomas.

Ivanov SV, Panaccione A, Nonaka D, Prasad ML, Boyd KL, Brown B, Guo Y, Sewell A, Yarbrough WG.

Br J Cancer. 2013 Jul 23;109(2):444-51. doi: 10.1038/bjc.2013.326. Epub 2013 Jun 25.


Expression Profiling of Clinical Specimens Supports the Existence of Neural Progenitor-Like Stem Cells in Basal Breast Cancers.

Panaccione A, Guo Y, Yarbrough WG, Ivanov SV.

Clin Breast Cancer. 2017 Jul;17(4):298-306.e7. doi: 10.1016/j.clbc.2017.01.007. Epub 2017 Jan 27.


Developmental transcription factor EN1--a novel biomarker in human salivary gland adenoid cystic carcinoma.

Bell D, Bell A, Roberts D, Weber RS, El-Naggar AK.

Cancer. 2012 Mar 1;118(5):1288-92. doi: 10.1002/cncr.26412. Epub 2011 Jul 28.


In-depth characterization of the salivary adenoid cystic carcinoma transcriptome with emphasis on dominant cell type.

Bell D, Bell AH, Bondaruk J, Hanna EY, Weber RS.

Cancer. 2016 May 15;122(10):1513-22. doi: 10.1002/cncr.29959. Epub 2016 Mar 8.


SOX10 is a novel marker of acinus and intercalated duct differentiation in salivary gland tumors: a clue to the histogenesis for tumor diagnosis.

Ohtomo R, Mori T, Shibata S, Tsuta K, Maeshima AM, Akazawa C, Watabe Y, Honda K, Yamada T, Yoshimoto S, Asai M, Okano H, Kanai Y, Tsuda H.

Mod Pathol. 2013 Aug;26(8):1041-50. doi: 10.1038/modpathol.2013.54. Epub 2013 Apr 5.


NOTCH1 and SOX10 are Essential for Proliferation and Radiation Resistance of Cancer Stem-Like Cells in Adenoid Cystic Carcinoma.

Panaccione A, Chang MT, Carbone BE, Guo Y, Moskaluk CA, Virk RK, Chiriboga L, Prasad ML, Judson B, Mehra S, Yarbrough WG, Ivanov SV.

Clin Cancer Res. 2016 Apr 15;22(8):2083-95. doi: 10.1158/1078-0432.CCR-15-2208.


Study of FHIT and WWOX expression in mucoepidermoid carcinoma and adenoid cystic carcinoma of salivary gland.

Dincer N, Tezel GG, Sungur A, Himmetoglu C, Huebner K, Güler G.

Oral Oncol. 2010 Mar;46(3):195-9. doi: 10.1016/j.oraloncology.2009.12.003. Epub 2010 Jan 8.


Adenoid cystic carcinomas of the breast and salivary glands (or 'The strange case of Dr Jekyll and Mr Hyde' of exocrine gland carcinomas).

Marchiò C, Weigelt B, Reis-Filho JS.

J Clin Pathol. 2010 Mar;63(3):220-8. doi: 10.1136/jcp.2009.073908. Review.


MicroRNA profiling of salivary adenoid cystic carcinoma: association of miR-17-92 upregulation with poor outcome.

Mitani Y, Roberts DB, Fatani H, Weber RS, Kies MS, Lippman SM, El-Naggar AK.

PLoS One. 2013 Jun 25;8(6):e66778. doi: 10.1371/journal.pone.0066778. Print 2013.


Expression of ERBB3 binding protein 1 (EBP1) in salivary adenoid cystic carcinoma and its clinicopathological relevance.

Sun J, Luo Y, Tian Z, Gu L, Xia SC, Yu Y.

BMC Cancer. 2012 Oct 30;12:499. doi: 10.1186/1471-2407-12-499.


Salivary duct carcinomas can be classified into luminal androgen receptor-positive, HER2 and basal-like phenotypes.

Di Palma S, Simpson RH, Marchiò C, Skálová A, Ungari M, Sandison A, Whitaker S, Parry S, Reis-Filho JS.

Histopathology. 2012 Oct;61(4):629-43. doi: 10.1111/j.1365-2559.2012.04252.x.


Identification of methylated genes in salivary gland adenoid cystic carcinoma xenografts using global demethylation and methylation microarray screening.

Ling S, Rettig EM, Tan M, Chang X, Wang Z, Brait M, Bishop JA, Fertig EJ, Considine M, Wick MJ, Ha PK.

Int J Oncol. 2016 Jul;49(1):225-34. doi: 10.3892/ijo.2016.3532. Epub 2016 May 18.


Evaluation of MYB promoter methylation in salivary adenoid cystic carcinoma.

Shao C, Bai W, Junn JC, Uemura M, Hennessey PT, Zaboli D, Sidransky D, Califano JA, Ha PK.

Oral Oncol. 2011 Apr;47(4):251-5. doi: 10.1016/j.oraloncology.2011.01.008. Epub 2011 Feb 15.


Molecular differences in mucoepidermoid carcinoma and adenoid cystic carcinoma of the major salivary glands.

Gibbons MD, Manne U, Carroll WR, Peters GE, Weiss HL, Grizzle WE.

Laryngoscope. 2001 Aug;111(8):1373-8.


Diagnostic role of DOG1 and p63 immunohistochemistry in salivary gland carcinomas.

Abd Raboh NM, Hakim SA.

Int J Clin Exp Pathol. 2015 Aug 1;8(8):9214-22. eCollection 2015.


IMP3, a proposed novel basal phenotype marker, is commonly overexpressed in adenoid cystic carcinomas but not in apocrine carcinomas of the breast.

Vranic S, Gurjeva O, Frkovic-Grazio S, Palazzo J, Tawfik O, Gatalica Z.

Appl Immunohistochem Mol Morphol. 2011 Oct;19(5):413-6. doi: 10.1097/PAI.0b013e3182143399.


Overexpression of macrophage migration inhibitory factor in adenoid cystic carcinoma: correlation with enhanced metastatic potential.

Liu H, Chen G, Zhang W, Zhu JY, Lin ZQ, Gong ZC, Wang FQ, Jia J, Sun ZJ, Zhao YF.

J Cancer Res Clin Oncol. 2013 Feb;139(2):287-95. doi: 10.1007/s00432-012-1330-z. Epub 2012 Oct 12.


Supplemental Content

Support Center